Covishield Vaccine Is Astrazeneca/Oxford University Vaccine
, AstraZeneca and Oxford University (AZOU) originally developed the ChAdOx1 recombinant adenoviral vector vaccine to be used for prevention of COVID-19 disease. AZOU gave the license of its vaccine to Serum Institute of India PVT Ltd (SIIPL) to manufacture this vaccine at commercial scale. SIIPL is the largest vaccine manufacturer in the world and the […]